Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851876566
Publisher
SAGE Publications
Online
2018-03-15
DOI
10.1177/1352458518765666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study
- (2017) René-Maxime Gracien et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study
- (2017) Arianna Sartori et al. JOURNAL OF NEUROLOGY
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Serum neurofilament is associated with progression of brain atrophy and disability in early MS
- (2017) Jens Kuhle et al. NEUROLOGY
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Long-term evolution of multiple sclerosis disability in the treatment era
- (2016) et al. ANNALS OF NEUROLOGY
- The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain
- (2016) Lukas Haider et al. BRAIN
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
- (2016) Pierre de Flon et al. NEUROLOGY
- Secondary Progression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
- (2016) Catherine Larochelle et al. TRENDS IN NEUROSCIENCES
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Disease Activity Free Status
- (2014) Carolyn J. Bevan et al. JAMA Neurology
- Neurofilaments as biomarkers in multiple sclerosis
- (2012) Charlotte E Teunissen et al. Multiple Sclerosis Journal
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now